Literature DB >> 6460044

Complex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogen.

R L Nachman, L L Leung.   

Abstract

We have recently reported the isolation of purified platelet membrane glycoproteins IIb and IIIa and the generation of monospecific antisera to these membrane proteins. Using these monospecific antisera in an enzyme-linked immunosorbent assay system, it is no demonstrated that glycoprotein IIb (GPIIb) and glycoprotein IIIa (GPIIIa) form a complex with purified human fibrinogen. The formation of this GPIIb-GPIIIa fibrinogen complex is calcium dependent, fibrinogen specific, saturable, and inhibited by specific amino sugars and amino acids. These observations suggest that the GPIIb-GPIIIa macromolecular complex on the platelet surface acts under the proper physiologic circumstances as the fibrinogen binding site required for normal platelet aggregation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6460044      PMCID: PMC370974          DOI: 10.1172/jci110448

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  A molecular defect in thrombasthenic platelets.

Authors:  L Degos; A Dautigny; J C Brouet; M Colombani; N Ardaillou; J P Caen; J Colombani
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

2.  Human platelets possess an inducible and saturable receptor specific for fibrinogen.

Authors:  G A Marguerie; E F Plow; T S Edgington
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

3.  Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads.

Authors:  P Cuatrecasas
Journal:  J Biol Chem       Date:  1970-06       Impact factor: 5.157

4.  Plasminogen: purification from human plasma by affinity chromatography.

Authors:  D G Deutsch; E T Mertz
Journal:  Science       Date:  1970-12-04       Impact factor: 47.728

5.  The cold-insoluble globulin of human plasma. I. Purification, primary characterization, and relationship to fibrinogen and other cold-insoluble fraction components.

Authors:  M W Mosesson; R A Umfleet
Journal:  J Biol Chem       Date:  1970-11-10       Impact factor: 5.157

6.  Membrane protein analysis by two-dimensional immunoelectrophoresis.

Authors:  C A Converse; D S Papermaster
Journal:  Science       Date:  1975-08-08       Impact factor: 47.728

7.  Immunoinhibition of ristocetin-induced platelet aggregation.

Authors:  R L Nachman; E A Jaffe; B B Weksler
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

8.  Acquired IgG antibody occurring in a thrombasthenic patient: its effect on human platelet function.

Authors:  S Levy-Toledano; G Tobelem; C Legrand; R Bredoux; L Degos; A Nurden; J P Caen
Journal:  Blood       Date:  1978-06       Impact factor: 22.113

9.  Thrombin-induced platelet aggregation is mediated by a platelet plasma membrane-bound lectin.

Authors:  T K Gartner; D C Williams; F C Minion; D R Phillips
Journal:  Science       Date:  1978-06-16       Impact factor: 47.728

10.  Subcellular platelet factor VIII antigen and von Willebrand factor.

Authors:  R L Nachman; E A Jaffe
Journal:  J Exp Med       Date:  1975-05-01       Impact factor: 14.307

View more
  56 in total

1.  Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen.

Authors:  H Ni; C V Denis; S Subbarao; J L Degen; T N Sato; R O Hynes; D D Wagner
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  The Structure of a Full-length Membrane-embedded Integrin Bound to a Physiological Ligand.

Authors:  Aguang Dai; Feng Ye; Dianne W Taylor; Guiqing Hu; Mark H Ginsberg; Kenneth A Taylor
Journal:  J Biol Chem       Date:  2015-09-21       Impact factor: 5.157

3.  Imaging thrombus with radiolabelled monoclonal antibody to platelets.

Authors:  A M Peters; J P Lavender; S G Needham; I Loutfi; D Snook; A A Epenetos; P Lumley; R J Keery; N Hogg
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-13

4.  Protein kinase C and cyclic AMP regulate reversible exposure of binding sites for fibrinogen on the glycoprotein IIB-IIIA complex of human platelets.

Authors:  G van Willigen; J W Akkerman
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

Review 5.  The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend.

Authors:  Barry S Coller; Sanford J Shattil
Journal:  Blood       Date:  2008-10-15       Impact factor: 22.113

Review 6.  Current concepts of platelet activation: possibilities for therapeutic modulation of heterotypic vs. homotypic aggregation.

Authors:  Gabriella Passacquale; Albert Ferro
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

Review 7.  Characteristics of an ADP receptor mediating platelet activation.

Authors:  R W Colman; W R Figures
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

8.  Retention of the glycoprotein IIb-IIIa complex in the isolated platelet cytoskeleton. Effects of separable assembly of platelet pseudopodal and contractile cytoskeletons.

Authors:  M E Wheeler; A C Cox; R C Carroll
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

9.  Spatial distribution of factor Xa, thrombin, and fibrin(ogen) on thrombi at venous shear.

Authors:  Michelle A Berny; Imke C A Munnix; Jocelyn M Auger; Saskia E M Schols; Judith M E M Cosemans; Peter Panizzi; Paul E Bock; Steve P Watson; Owen J T McCarty; Johan W M Heemskerk
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

10.  External validation suggests Integrin beta 3 as prognostic biomarker in serous ovarian adenocarcinomas.

Authors:  Karolina Partheen; Kristina Levan; Lovisa Osterberg; Ingela Claesson; Karin Sundfeldt; György Horvath
Journal:  BMC Cancer       Date:  2009-09-23       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.